Company Filing History:
3 out of 43 
1 out of 247 
1 out of 1 Years Active: 1999-2009
Title: Inventor Spotlight: Nicholas P. Barker
Introduction
Nicholas P. Barker is a notable inventor based in Southborough, Massachusetts, with a strong background in biopharmaceutical innovations. Throughout his career, he has been granted five patents, contributing significantly to advancements in drug delivery systems and biotechnology.
Latest Patents
Among his most recent patents are the yeast expression vectors designed for the production of ITF (interferon transgenes). This innovation includes ITF expression vectors and methods aimed at enhancing production efficiency. Another vital patent focuses on pharmaceutical formulations for sustained drug delivery. This particular formulation features a water-insoluble complex of a peptide and a carrier macromolecule, which allows for the loading of high concentrations of peptide in a minimal volume. Such formulations enable prolonged delivery of active peptides, potentially extending the treatment period for up to one month following administration. In this case, the peptide of the complex is an LHRH analogue, preferably an LHRH antagonist, complemented by an anionic polymer carrier, like carboxymethylcellulose. The invention also includes methods for creating these complexes and employing LHRH-analogue-containing complexes to address various treatable conditions.
Career Highlights
Throughout his career, Barker has worked with leading companies, including Praecis Pharmaceuticals, Inc. and Rhône-Poulenc Rorer S.A. His professional journey reflects a commitment to innovative solutions in the pharmaceutical sector, especially in developing effective drug delivery systems.
Collaborations
Collaborating with esteemed professionals in the field, Barker has had the opportunity to work alongside individuals such as Malcolm L. Gefter and Gary Fred Musso. These collaborations have likely enhanced the impact and reach of his innovative work.
Conclusion
In summary, Nicholas P. Barker’s contributions to the fields of biotechnology and pharmaceutical formulations exemplify the spirit of innovation. With his impressive array of patents and collaborative efforts, he continues to pave the way for advancements that can significantly improve therapeutic strategies in medicine.